Effervescent naproxen tablets now available

Stirlescent is the first licensed effervescent formulation of naproxen. It is indicated in the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, acute musculoskeletal disorders, dysmenorrhoea and acute gout in adults.

Further information
View Stirlescent drug record
Summary of Product Characteristics
Manufacturer: Stirling Anglian

The NHS list price of Stirlescent is £7.90 for a pack of 20 blackcurrant-flavoured 250mg tablets.

Stirlescent has been accepted for restricted use within NHS Scotland in patients unable to swallow naproxen tablets.

As with all NSAIDs, the lowest effective dose should be used for the shortest duration necessary to control symptoms.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases